Stay updated on Oral Insulin Immune Effects in Type 1 Diabetes Risk Clinical Trial
Sign up to get notified when there's something new on the Oral Insulin Immune Effects in Type 1 Diabetes Risk Clinical Trial page.

Latest updates to the Oral Insulin Immune Effects in Type 1 Diabetes Risk Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe Locations section now includes additional site locations across California, Colorado, Florida, Georgia, Illinois, Indiana, Massachusetts, New York, Pennsylvania, Tennessee, Texas, Washington, Victoria (Australia), and Ontario (Canada). The HHS Vulnerability Disclosure link was removed.SummaryDifference2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRemoved the topic 'Type 1 diabetes' and the related topic 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check35 days agoChange DetectedAdded related topics for Type 1 diabetes and MedlinePlus Genetics.SummaryDifference0.2%

- Check43 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not all pertain to the study, and added Revision: v3.3.2; the older PubMed wording with Revision: v3.2.0 was removed.SummaryDifference0.1%

- Check50 days agoChange DetectedNotice about government funding lapse and potential data recency was removed from the page.SummaryDifference0.3%

- Check64 days agoChange DetectedNo significant changes were detected on the Study Details page (NCT02580877) compared with the previous version.SummaryDifference0.4%

Stay in the know with updates to Oral Insulin Immune Effects in Type 1 Diabetes Risk Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Insulin Immune Effects in Type 1 Diabetes Risk Clinical Trial page.